36E79725D0044
Indefinite Delivery Contract
Overview
Government Description
NEW AWARD FOR BUSPIRONE HCL TABLETS WITH RADHA. ORDERING PERIOD IS OCT 3, 2025 TO OCT 2, 2026 WITH FOUR ONE-YEAR OPTIONS
Awardee
Awarding / Funding Agency
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Multiple Agencies
Vehicle Ceiling
$18,126,658 (0% Used)
Related Opportunity
Radha Pharmaceuticals was awarded
Indefinite Delivery Contract 36E79725D0044 (36E797-25-D-0044)
by
National Acquisition Center
for New Award For Buspirone Hcl Tablets With Radha. Ordering Period Is Oct 3, 2025 To Oct 2, 2026 With Four One-Year Options
in October 2025.
The IDC
was awarded
through solicitation Buspirone RFP
full & open
with
NAICS 325412 and
PSC 6505
via direct negotiation acquisition procedures with 5 bids received.
The total ceiling is $18,126,658, of which 0% has been used.
Status
(Open)
Modified 8/6/25
Period of Performance
10/2/25
Start Date
10/2/26
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for 36E79725D0044
Transaction History
Modifications to 36E79725D0044
People
Suggested agency contacts for 36E79725D0044
Competition
Number of Bidders
5
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
C1S5SQ88KY67
Awardee CAGE
8PNH3
Agency Detail
Awarding Office
36E797 NAC PHARMACEUTICALS (36E797)
Funding Office
36E797 NAC PHARMACEUTICALS (36E797)
Created By
amber.zavala@va.gov
Last Modified By
diana.eaton@va.gov
Approved By
diana.eaton@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
NY-01
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Nicolas LaLota
Last Modified: 8/6/25